Identification of Pt(II) and Pd(II) stereoisomeric complexes with aminobutyric acid by NMR and IR spectroscopy

Complexes of Pd(II) with aminobutyric acid AmH = NH₂CH(CH₂CH₃)COOH, namely, trans-[Pd(AmH)₂Cl₂] with monodentate (via the NH₂ group) AmH ligands and cis-, trans-Pd(Am)₂ with bidentate (via NH₂ and COO groups) ligands have been synthesized for the first time. Elemental analysis and IR and NMR spectroscopy were used to identify the synthesized compounds. The NMR spectra of the Pd(II) complexes were interpreted by comparing them with the NMR spectra of the analogous complexes of Pt(II). For Pt(II) and Pd(II) complexes with aminobutyric acid used as examples, an approach to identification of diastereomer bis-aminoacid complexes in specimens with racemic aminoacids by NMR spectroscopy is demonstrated.     

Synthesis and structure of Pt(II) acetamidate complexes containing <Emphasis Type="Italic">N</Emphasis>,<Emphasis Type="Italic">N</Emphasis>-dimethyl-substituted ethylenediamine and trimethylenediamine

Reactions of acetamide with platinum(II) diamines [Pt(N,N-DimeEn)Cl₂], [Pt(Tm)Cl₂], and [Pt(N,N-DimeTm)Cl₂] (N,N-DimeEn = (CH₃)₂N(CH₂)₂NH₂, Tm = NH₂(CH₂)₃NH₂, N,N-DimeTm = (CH₃)₂N(CH₂)₃NH₂) with preliminary precipitation of chlorine ions by silver salts gave binuclear Pt(II) acetamidates [Pt₂(CH₃)₂N(CH₂)₂NH₂)₂(μ-NHCOCH₃)₂](NO₃)₂ · H₂O (I), [Pt₂(NH₂(CH₂)₃NH₂)₂)(μ-NHCOCH₃)₂](NO₃)₂ · H₂O (II), and [Pt₂(CH₃)₂N(CH₂)₃NH₂)₂(μ-NHCOCH₃)₂](HSO₄)₂ (III), whose crystal structures were determined. Crystals of I are monoclinic: a = 14.459(2) Å, b = 17.197(3) Å, c = 9.822(2) Å, β = 105.923(10)°, V = 3348.6(8) ų, space group P2(1)/c, Z = 4, R _hkl = 0.0419 for 6663 reflections. Complex I is a binuclear acetamidate with bridging (NHCOCH₃)^? ligands, one of which is bound to two Pt atoms through the N and O atoms, and the other ligand is bound only through the N atom. The Pt-Pt distance is 2.987(1) Å. Crystals of II are monoclinic: a = 10.213(7) Å, b = 13.373(9) Å, c = 16.533(11) Å, β = 97.971(9)°, V = 2236(3) ų, space group P2(1)/n, Z = 4, R _hkl = 0.557 for 6462 reflections. The Pt-Pt distance is 3.057(1) Å. Crystals of III are monoclinic: a = 10.557(12) Å, b = 18.531(2) Å, c = 14.4744(17) Å, β = 108.705(2)°, V = 2682(5) ų, space group P2(1)/n, Z = 4, R _hkl = 0.569 for 8506 reflections. The Pt-Pt distance is 3.202(1) Å. Complexes II and III are binuclear acetamidates, in which two chelating Pt(Tm) or Pt(N,N-DimeTm) moieties are coordinated through the N and O atoms of (NHCOCH₃)^? cis-bridges.     

Synthesis,DFT calculations and characterisation of new mixed Pt(II) complexes with 3-thiolanespiro-5<Emphasis Type="Italic">′</Emphasis>-hydantoin and 4-thio-1<Emphasis Type="Italic">H</Emphasis>-tetrahydropyranspiro-5<Emphasis Type="Italic">′</Emphasis>-hydantoin

Cisplatin is an anticancer drug widely used in the treatment of a wide range of solid tumours (head and neck, lung, bladder etc.), testicular and ovarian cancers. Because of its severe toxicity profile and spontaneous development of drug resistance in tumours, a number of Pt(II) complexes have been synthesised and tested for anti-tumour activity. Some of the investigations have focused on using ligands bearing donor atoms other than N (e.g., S, P, O). Two new mixed Pt(II) complexes of the general formula cis-[Pt(NH₃)LCl₂] where L is 3-thiolanespiro-5′-hydantoin and 4-thio-1H-tetrahydropyranspiro-5′-hydantom were synthesised. The complexes were studied by elemental analysis, melting points, IR and ¹H NMR spectra. The hybrid DFT calculations were used for optimisation of the structure geometries of the ligands III, IV and their Pt(II) complexes V and VI. The structural parameters so calculated, such as bond lengths and angles, are in good agreement with the experimental data for similar hydantoins and their platinum complexes. The results showed that the geometries of complexes V and VI are plane square and the bounding of ligands III and IV with platinum ions is effected by the sulphur atom from the cyclic ring. The complexes thus obtained were chemically examined in comparison with previously synthesised and published complexes of the general formula cis-[PtL₂Cl₂] (VII and VIII) with the same ligands. The new compounds V and VI, as well as the previously investigated complexes (VII and VIII), were analysed for cytotoxicity in vitro on SKW-3 and HL-60 human tumour cell lines. The results showed that all the complexes exerted concentration-dependent anti-proliferative activity.     

Structure and thermal properties of a novel volatile bis(1,1,1-trifluoro-5,5-dimethyl-3-hexene-4-imino-2-onate) platinum(II) compound

A novel volatile Pt(II)β-iminoketonate complex is synthesized. β-Aminovinylketone H(i-ptac) = [CF₃–C(O)–CH=C(NH₂)–C(CH₃)₃] is used as a ligand. The XRD method is used to determine the structures of the ligand and the complex. The crystallographic data for C₁₆H₂₂F₆N₂O₂Pt are as follows: a = 10.0716(4) Å, b = 10.9572(4) Å, c = 9.6322(4) Å, β = 110.9010(10)°, space group С2/m, Z = 2, R = 0.011. The platinum atom has a square planar coordination with two oxygen and two nitrogen atoms of two bidentately linked ketoiminate ligands in trans-position; the PtO₂N₂ coordination site is formed.     

Synthesis and study of hexaamminecadmium hydrogen hexamolybdocobaltate(III) and hexamolybdochromate(III)

Hexaamminecadmium hydrogen hexamolybdocobaltate(III) and hydrogen hexamolybdochromate(III) of compositions [Cd(NH₃)₆] · H[CoMo₆O₁₈(OH)₆] · 6H₂O (I) and [Cd(NH₃)₆] · H[CrMo₆O₁₈(OH)₆] · 6H₂O (II), respectively, were synthesized and studied by mass spectroscopy, thermo-gravimetry, X-ray powder diffraction, and IR spectroscopy. Crystals of I and II are monoclinic. For I: a = 10.79 Å, b = 3.70 Å, c = 11.95 Å, β = 91.05°, V = 470.12 ų, ρ_calc = 2.37 g/cm³, Z = 2; and for II: a = 10.80 Å, b = 3.68 Å, c = 11.97 Å, β = 91.07°, V = 468.98 ų, ρ_calc = 2.36 g/cm³, Z = 2.     

Crystal structure of di-μ-amido-bis[diammineplatinum(II)] nitrate

Di-μ-amido-bis[diammineplatinum(II)] nitrate (1) was synthesized as a byproduct during preparation of tetraammineplatinum(II) nitrate. One possible pathway to produce 1 is that [(H₃N)₂Pt(μ- OH)₂Pt(NH₃)₂](NO₃)₂, a well-known complex forming on treatment of cis-Pt(NH₃)₂I₂ with AgNO₃, reacts with aqueous ammonia. The other possible pathway involves deprotonation of [Pt(NH₃)₄](NO₃)₂ to form monomeric Pt(NH₃)₃(NH₂)NO₃ followed by elimination of NH3. Crystals of 1 (from water) are monoclinic (C2/c) with a = 16.834(2) Å, b = 10.573(1) Å, c = 7.415(1) Å, β = 114.846(1)°, and Z = 4. The cationic portion consists of two symmetrical square-planar Pt centers with the inversion center at the midpoint of the Pt(1)???Pt(1A) vector. The Pt(II) ion is coordinated by four N atoms from two ammonia molecules and two bridging amido groups affording a slightly distorted square. The molecules are stacked in such a way that the planes of coordination squares turn out to be parallel to each other with a distance of 3.501 Å. Intermolecular Pt–H interaction between the μ-NH₂ hydrogens and the platinum(II) centers of the adjacent molecule are observed.     

Tetramminenickel hydrogen hexamolybdometalates(III)

Tetramminenickel hydrogen hexamolybdoaluminate and hexamolybdogallate(III) of compositions [Ni(NH₃)₄] · H[AlMo₆O₁₈(OH)₆] · 10H₂O (I) and [Ni(NH₃)₄] · H[GaMo₆O₁₈(OH)₆] · 10H₂O (II) were synthesized and characterized by mass spectrometry, thermogravimetry, X-ray powder diffraction, and IR spectroscopy. Their crystals are triclinic. For compound I, a= 17.30 Å, b= 14.69 Å, c= 10.45 Å, α = 129.07, β = 65.91°, γ = 138.01°, V = 1338.7l ų, ρ_calcd = 2.75g/cm³, Z = 2; for compound II, a = 17.38 Å, b= 14.75 Å, c= 10.51 Å, α = 131.38°, β= 65.96°, γ = 138.09, V = 1338.15 ų, ρ_calcd = 2.68 g/cm³, Z = 2.     

Synthesis,characterization, and cytotoxicity of Pt(IV) complexes containing 1,10-phenanthroline and 2,2′-bipyridine and diaminocyclohexane ligands

Four platinum(IV) complexes containing intercalating ligands [1,10-phenanthroline (phen) and 2,2′-bipyridine (bpy)] and ancillary ligands [(1S,2S)-diaminocyclohexane (SS-DACH) and (1R,2R)-diaminocyclohexane (RR-DACH)] were synthesized and characterized by ¹H nuclear magnetic resonance, electrospray ionization mass spectrometry, X-ray crystal structure analysis, elemental analysis, ultraviolet absorption spectroscopy, circular dichroism spectroscopy, and electrochemical analysis. The reactions between [Pt(phen)(SS-DACH)Cl₂]²⁺ and glutathione and Ac-CPFC-NH₂ were investigated by high-performance liquid chromatography. [Pt(phen)(SS-DACH)Cl₂]²⁺ was reduced to its corresponding Pt(II) complex [Pt(phen)(SS-DACH)]²⁺, while glutathione and Ac-CPFC-NH₂ were oxidized to glutathione-disulfide and a peptide containing an intramolecular disulfide bond, respectively. The cytotoxicities of the Pt(IV) complexes against a human non-small cell lung cancer cell line (A549) and the corresponding cisplatin-resistant cell line (A549cisR) were evaluated. These Pt(IV) complexes showed a higher activity toward A549 and A549cisR than did cisplatin. Also, the cytotoxicities of the Pt(IV) complexes were higher for A549cisR than for A549 cells. Moreover, the cytotoxicities of the (SS-DACH)-liganded platinum complexes were higher than those of the (RR-DACH)-liganded platinum complexes in either A549 or A549cisR cells. Phen-liganded platinum complexes were more cytotoxic than the bpy-liganded platinum complexes. The cytotoxicities of these Pt(IV) complexes had no correlation with reduction potentials.     

Structural investigation of salts containing ions [Pd(NH<Subscript>3</Subscript>)<Subscript>4</Subscript>]<Superscript>2+</Superscript> and [IrF<Subscript>6</Subscript>]<Superscript>2–</Superscript>

Double complex salts (DCS) α-[Pd(NH₃)₄][IrF₆]·H₂O (P2₁/m, a = 6.3181(3) Å, b = 10.8718(5) Å, с = 7.4526(4) Å, β = 103.568(2)°), β-[Pd(NH₃)₄][IrF₆]·H₂O (P2₁/с, a = 8.5773(3) Å, b = 10.8791(4) Å, с = = 12.6741(3) Å, β = 122.497(2)°), [Pd(NH₃)₄]₃[IrF₆]₂Cl₂·H₂O (P-1, a = 7.6080(2) Å, b = 7.6274(2) Å, с = 11.8070(3) Å, β = 122.497(2)°), and [Pd(NH₃)₄]₂[IrF₆]NO₃ (Fm-3m, a = 11.21210(10) Å) have been synthesized and structurally characterized for the first time. The existence of polymorphs for the DCS has been revealed. The influence of the chemical composition of the initial reagents on the reaction course and, respectively, the products, has been demonstrated. A hypothesis on the influence of the second coordination sphere on the formation of one or the other polymorph of the DCS has been suggested. It has been shown that the series α-[Pd(NH₃)₄][МF₆]·H₂O (M = Pt, Pd) exhibits isostructurality.     

Crystal structure of [Ir(NH<Subscript>3</Subscript>)<Subscript>5</Subscript>Cl]<Subscript>2</Subscript>[OsCl<Subscript>6</Subscript>]Cl<Subscript>2</Subscript>. Crystal-chemical analysis of the iridium-osmium system

The [Ir(NH₃)₅Cl]₂[OsCl₆]Cl₂ binary complex salt has been prepared, and its structure was investigated by single crystal X-ray diffraction. Crystal data: a = 11.1901(13) Å, b = 7.9138(13) Å, c = 13.4384(18) Å; β = 99.640(3)°, V = 1190.0(2), space group C2/m, Z = 2, FW = 1099.47, d _x = 3.068 g/cm³. Thermolysis products of [Ir(NH₃)₅Cl]₂[OsCl₆]Cl₂, [Ir(NH₃)₅Cl][OsBr₆], (NH₄)₂[OsCl₆]_x[IrCl₆]_1?x , and K₂[OsCl₆]_x[IrCl₆]_1?x were studied by X-ray phase analysis; the unit cell parameters were refined, and the dependence of volume per atom (V/Z) on the composition of the Ir Os_1?x solid solution has been plotted.     

Synthesis and structure of highly substituted pyrazole ligands and their complexes with platinum(II) and palladium(II) metal ions

Reaction of 3-methoxycarbonyl-2-methyl- or 3-dimethoxyphosphoryl-2-methyl-substituted 4-oxo-4H-chromones 1 with N-methylhydrazine resulted in the formation of isomeric, highly substituted pyrazoles 4 (major products) and 5 (minor products). Intramolecular transesterification of 4 and 5 under basic conditions led, respectively, to tricyclic derivatives 7 and 8. The structures of pyrazoles 4a (dimethyl 2-methyl-4-oxo-4H-chromen-3-yl-phosphonate) and 4b (methyl 4-oxo-2-methyl-4H-chromene-3-carboxylate) were confirmed by X-ray crystallography. Pyrazoles 4a and 4b were used as ligands (L) in the formation of ML₂Cl₂ complexes with platinum(II) or palladium(II) metal ions (M). Potassium tetrachloroplatinate(II), used as the metal ion reagent, gave both trans-[Pt(4a)₂Cl₂] and cis-[Pt(4a)₂Cl₂], complexes with ligand 4a, and only cis-[Pt(4b)₂Cl₂] isomer with ligand 4b. Palladium complexes were obtained by the reaction of bis(benzonitrile)dichloropalladium(II) with the test ligands. trans-[Pd(4a)₂Cl₂] and trans-[Pd(4b)₂Cl₂] were the exclusive products of these reactions. The structures of all the complexes were confirmed by IR, ¹H NMR and FAB MS spectral analysis, elemental analysis and Kurnakov tests.     

Hydrolysis of coordinated aminoacetonitrile in a platinum(IV) complex. Crystal structure of [PtPy(NH<Subscript>2</Subscript>CH<Subscript>2</Subscript>COO)Cl<Subscript>3</Subscript>]

Heating of a hydrochloric acid solution of trans-PtPy(NH₂CH₂CN)Cl₄ results in the hydrolysis of coordinated aminoacetonitrile to aminoacetic acid with the formation of a five-membered chelate ring attached to platinum through the nitrogen atom of the amino group and the oxygen atom of the carboxy group. X-ray diffraction analysis of [PtPy(NH₂CH₂COO)Cl₃] is carried out. The crystals are monoclinic: space group C2/c, a = 21.704(2), b = 8.7027(7), c = 15.576(1) Å, β = 126.606(1)^o, V = 2361.8(3) ų, Z = 8; R _hkl = 0.057, wR = 0.141. In the neutral complex, the Pt atom has a distorted octahedral coordination. The equatorial plane is formed by a Cl atom (Pt-Cl, 2.284(3) Å), the N atom of the Py molecule (Pt-N, 2.062(8) Å), and the N and O atoms of the bidentate-chelating ligand (Pt-N, 2.039(8); Pt-O, 2.026(7) Å); two Cl atoms are arranged in the apical positions (Pt-Cl, 2.301(3) and 2.312(3) Å). The five-membered chelate ring has a flattened gauche conformation with an NCCO torsion angle of 19(1)°.     

Crystal and molecular structure of guanidinium dicitratoferrate(II)

Synthesis and X-ray investigation of a (GunH)₂[Fe(Cit)₂] single crystal are described [a = 10.327(2) Å, b = 10.414(2) Å, c = 11.267(2) Å; β = 117.25(3)°, V = 1077.2(4) ų, P2₁/n, Z = 2, R(F) = 0,0239, 1196 reflections with I > 2σ(I )], where GunH is the guanidine cation (C(NH₂)₃)⁺, and Cit is the citric acid anion (C₆H₆O₇)^2?. The structure is composed of guanidinium cations and centrosymmetrical sym-cis-octahedral complex anions [Fe(Cit)₂]^2?. The Cit^2? anion acts as a cyclic tridentate ligand and forms condensed fiveand six-membered metal-containing cycles.     

HPLC Method for the Determination of the Purity of K[Pt(NH3)Cl3], a Precursor of the Platinum Complexes with Cytostatic Activity

K[Pt(NH₃)Cl₃], a valuable precursor for the preparation of platinum complexes with cytostatic activity, e.g. satraplatin, picoplatin, LA-12 and cycloplatam, is currently prepared from cis-[Pt(NH₃)₂Cl₂] or K₂[PtCl₄] and these are the usual impurities in the final product. A simple, selective and sensitive HPLC-UV analytical method for the determination of the purity of K[Pt(NH₃)Cl₃] and the quantification of the impurities has been developed and validated. The platinum complexes present in the final product were separated on a strong base ion exchange column by the gradient elution with detection at 213 nm. Intra-assay precisions for the platinum complexes respective to their ions ([PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂]) were between 0.1 and 2.0% (relative standard deviation); intermediate precisions were between 1.4 and 2.0% and accuracies were between 98.6 and 101.4%. Limits of detection of [PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂] were 6 µg · ml^?1, 13 mg · ml^?1 and 5 µg · ml^?1 respectively, limits of quantification of [PtCl₄]^2?, [Pt(NH₃)Cl₃]^? and cis-[Pt(NH₃)₂Cl₂] were 51 µg · ml^?1, 55 mg · ml^?1 and 20 µg · ml^?1 respectively.     

Thermolysis of [Pt(NH<Subscript>3</Subscript>)<Subscript>4</Subscript>][ReHlg<Subscript>6</Subscript>] (Hlg = Cl,Br). Structure refinement for [Pt(NH<Subscript>3</Subscript>)<Subscript>4</Subscript>][ReCl<Subscript>6</Subscript>]

Thermal decomposition of [Pt(NH₃)₄][ReHlg₆] binary complex salts (Hlg = Cl, Br) in a hydrogen atmosphere has been studied. Polycrystal X-ray diffractometry indicated that two-phase metallic systems are the final products of thermolysis. Structure refinement was performed for [Pt(NH₃)₄][ReCl₆] by the combined technique involving decomposition of the diffractogram into individual reflections, isolation of reflections most sensitive to the position of separate light atoms, and full-profile analysis. Crystal data for PtReN₄Cl₆H₁₂: a = 11.616(1) Å, b = 10.998(1) Å, c = 10.377(1) Å, V = 1148.1 ų, space group Cmca, Z = 4, d _x = 3.831 g/cm³. The indices are R_p = 5.48%, R_wp = 10.01%, R(F²) = 12.62%. The coordination polyhedron of Re is an almost regular octahedron: Re-Cl 2.34–2.36 Å, ∠ Cl-Re-Cl 86.9–90.3°; the coordination polyhedron of Pt is a square: Pt-N 2.04 Å, ∠N-Pt-N 90.4°.     

Crystal structures of <Emphasis Type="Italic">trans</Emphasis>-dichlorobis(ethylendiamine) rhodium(III) with univalent anions

The crystal structures of the compounds trans-[Rh(en)₂Cl₂]Cl₂ · H₅O₂ (I), trans-[Rh(en)₂Cl₂]ClO₄ (II), and trans-[Rh(en)₂Cl₂]ReO₄ (III) are determined. The crystal data are: I, a = 10.860(3) Å, b = 7.795(2) Å, c = 9.023(3) Å; β = 111.56(10)°, P2₁/c space group, Z = 4, d _x = 1.875 g/cm³; II, a = 6.593(2) Å, b = 8.309(3) Å, c = 11.922(4) Å, α = 83.55(10)°, β = 79.80(10)°, γ = 75.38(10)°, P \(\bar 1\) space group, Z = 2, d _x = 2.106 g/cm³; III, a = 6.533(2) Å, b = 16.391(4) Å, c = 12.411(3) Å; β = 98.30(10)°, P2₁/c space group, Z = 4, d _x = 2.749 g/cm³. The compounds are examined by IR spectroscopy and powder XRD. The solubility of the isolated crystalline phases in water decreases in the following order: trans-[Rh(en)₂Cl₂]Cl₂·H₅O₂ > trans-[Rh(en)₂Cl₂]ClO₄ > trans-[Rh(en)₂Cl₂]ReO₄.     

Structure and properties of the volatile isomers of bis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato) of platinum(II)

In the work, isomeric complexes of platinum(II) with the (ptac)^–1 pivaloyltrifluoroacetonate ion (Pt((CH₃)₃–CO–CH–CO–CF₃)₂) are studied. The synthesis and chromatographic separation of Pt(ptac)₂ isomers are described, TGA data for the separated isomers are given, and the crystal structures of the solid phases are studied. The cis-Pt(ptac)₂ complex crystallizes in the space group P-1, a = 10.7091(4) Å, b = 12.7787(6) Å, c = 16.0154(8) Å, α = 92.389(2)°, β = 90.868(2)°, γ = 112.1260(10)°, V = 2027.39(16) ų, Z = 4, d _calc = 1.918 g/cm³. The trans-Pt(ptac)₂ complex crystallizes in the space group C2/m, a = 13.3235(5) Å, b = 8.5515(3) Å, c = 9.6694(3) Å, β = 118.5880(10)°, V = 967.38(6) Å3, Z = 2, d _calc = 2.010 g/cm3. The structures of the complexes are molecular, the Pt atom has a square coordination of four oxygen atoms of two ligands; for cis-Pt(ptac)2, the Pt–Oav distance is 1.968 Å, for trans-Pt(ptac)2 it is 1.980 Å.     

Crystal structure and luminescence of antimony(III) chloride complex with anilinium chloride

Crystal structure of (C₆H₅NH₃)₃[SbCl₅]Cl·H₂O is determined by X-ray analysis (a = 9.4155(13) Å, b = 11.4344(16) Å, c = 13.1584(18) Å, α = 113.483(2)°, β = 90.383(2)°, γ = 97.323(2)°, space group P \(\bar 1\), Z = 2, ρ_calc = 1.642 g/cm³). The crystal structure is based on [SbCl₅]^2? anions, anilinium cations (C₆H₅NH₃)⁺, isolated Cl^? anions, and water molecules. Structural features responsible for spectral and luminescent properties of the complex are discussed.     

Formation of Homo- and Heteronuclear Platinum(II) and Palladium(II) Carbene Complexes in the Reactions of Coordinated Isocyanides with Aminothiazaheterocycles

The reaction of 5-(trifluoromethyl)-1,3,4-thiadiazol-2-amine with cis-dichlorobis(2,6-dimethylphenyl isocyanide)platinum(II) (cis-[PtCl₂(CNXyl)₂], Xyl = 2,6-Me₂C₆H₃) gave platinum(II) monocarbene complex whose deprotonation with an organic base generated a nucleophilic species capable of reacting with palladium(II) and platinum(II) bis(isocyanide) complexes to afford homo- and heteronuclear isocyanide/carbene structures.     

A kinetic analysis of oxidation of the antioxidant <Emphasis Type="Italic">N</Emphasis>-acetyl-<Emphasis Type="SmallCaps">l</Emphasis>-cysteine (NAC) by Pt(IV) complexes

N-acetyl-l-cysteine (NAC) is an antioxidant and a supplement and has been demonstrated to have protective effects for a variety of toxic effects of heavy metals. Although previous works have shown that NAC can ameliorate the severe toxic effects of cisplatin, there is a lack of understanding of the interactions between NAC and Pt(IV)-based prodrugs. In this work, the oxidation of NAC by a cisplatin prodrug (cis-[Pt(NH₃)₂Cl₄]), by a prototype of Pt(IV) anticancer drug ormaplatin ([Pt(dach)Cl₄]) and by a model compound (trans-[PtCl₂(CN)₄]^2–) was characterized in detail. NAC was oxidized to NAC-disulfide as identified by mass spectrometric analysis. Time-resolved spectral and stopped-flow kinetic measurements were carried out over a wide pH range, demonstrating that the oxidation followed overall second-order kinetics. The observed second-order rate constants k′ versus pH profiles were established. A reaction mechanism was deduced, involving three parallel rate-determining steps; conceivable transition states were also proposed for these steps. Rate constants of the rate-determining steps, obtained from the simulations of rate equation to the k′–pH profiles, were largely correlated with the electron density on the sulfur atom in NAC. The Pt(IV) prodrugs can execute oxidative stress in the biological systems of the human body by direct oxidation of relevant molecules, similar to HOCl/OCl^? and chloroamines. Instead, the oxidative stress involved in the severe toxic effects of cisplatin is produced via a different mode. NAC could be a chemoprotecting agent also for the Pt(IV) anticancer drugs if recent drug delivery technologies are used.